THE BASIC PRINCIPLES OF GGTI298 TRIFLUOROACETATE

quinupristin/dalfopristin will enhance the amount or effect of lemborexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Prevent coadministration of lemborexant with average or strong CYP3A inhibitors.Watch Intently (one)quinupristin/dalfopristin will raise the stage or result of mavorixafor by infl